BF Biosciences Balance Sheet

Financials in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	288.13	344.47	278.77	255.44	211.67	421.69
Short-Term Investments	606.92	-	-	147.39	1,498	848.82
Trading Asset Securities	-	1,167	39.01	-	-	-
Cash & Short-Term Investments	895.05	1,511	317.78	402.83	1,710	1,271
Cash Growth	-37.78%	375.55%	-21.11%	-76.44%	34.58%	139.20%
Accounts Receivable	596.2	184.24	204.61	93.81	52.71	202.49
Other Receivables	-	45.51	49.33	49.64	-	-
Receivables	596.2	229.75	253.94	143.45	67.93	230.01
Inventory	2,734	1,740	893.81	852.24	406.55	356.16
Prepaid Expenses	-	5.34	5.88	2.28	-	-
Other Current Assets	394.13	349.88	205.26	190.5	110.93	98.97
Total Current Assets	4,619	3,836	1,677	1,591	2,295	1,956
Property, Plant & Equipment	4,482	4,306	4,175	4,070	2,135	1,034
Other Intangible Assets	2.7	3.98	0.55	1.11	-	-
Other Long-Term Assets	77.01	11.85	7.83	4.83	4.83	4.83
Total Assets	9,181	8,159	5,860	5,667	4,435	2,995
Accounts Payable	1,622	321.12	269.06	225.38	394.28	401.74
Accrued Expenses	17.06	541.51	266.09	144.7	13.82	6.74
Short-Term Debt	216.08	29.36	328.7	473.39	149.35	-
Current Portion of Long-Term Debt	340.49	328.05	292.72	356.88	57.65	16.32
Current Unearned Revenue	130.82	134.26	150.87	135.59	99.86	41.6
Other Current Liabilities	-	269.97	121.15	67.02	-	-
Total Current Liabilities	2,327	1,624	1,429	1,403	714.96	466.4
Long-Term Debt	1,167	1,367	1,591	1,772	1,537	873.06
Long-Term Unearned Revenue	241.05	318.37	432.6	503.73	331.33	172.67
Long-Term Deferred Tax Liabilities	318.87	186.58	48.31	13.51	26.55	15.99
Total Liabilities	4,054	3,497	3,500	3,693	2,610	1,528
Common Stock	265	265	190	190	190	190
Additional Paid-In Capital	1,780	1,780	-	-	-	-
Retained Earnings	3,082	2,617	2,170	1,784	1,502	1,200
Comprehensive Income & Other	-	-	-	-	132.7	76.27
Shareholders' Equity	5,127	4,662	2,360	1,974	1,825	1,467
Total Liabilities & Equity	9,181	8,159	5,860	5,667	4,435	2,995
Total Debt	1,724	1,725	2,212	2,603	1,744	889.38
Net Cash (Debt)	-828.77	-213.54	-1,894	-2,200	-34.26	381.13
Net Cash Growth	-	-	-	-	-	-27.32%
Net Cash Per Share	-9.38	-2.64	-29.91	-34.74	-0.54	6.02
Filing Date Shares Outstanding	88.46	88.33	63.33	63.33	63.33	63.33
Total Common Shares Outstanding	88.46	88.33	63.33	63.33	63.33	63.33
Working Capital	2,293	2,212	248.08	188.34	1,580	1,489
Book Value Per Share	57.96	52.78	37.26	31.17	28.82	23.16
Tangible Book Value	5,124	4,658	2,359	1,973	1,825	1,467
Tangible Book Value Per Share	57.93	52.73	37.25	31.15	28.82	23.16
Land	-	25.36	25.36	25.36	-	-
Buildings	-	993.57	236.06	214.16	-	-
Machinery	-	4,131	1,191	708.94	-	-
Construction In Progress	-	133.03	3,516	3,884	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.